Phase I randomized, placebo-controlled, cross-over dose-finding
pharmacokinetic study of Coenzyme Q10 during one cycle of doxorubicin
treatment for breast cancer
Heather Greenlee, ND, PhD, MPH1,2,3, Katherine D.
Crew, MD, MS1,2,4, Mathew Maurer,
MD2,4, Kevin Kalinsky, MD2,4, Serge
Cremers, PharmD, PhD5,6, Ali Naini,
PhD6,7, Wei Yann Tsai, PhD1,2,
Zaixing Shi, PhD1,6, Frances
Brogan2, Dawn L. Hershman, MD,
MS1,2,4
1 Mailman School of Public Health, Columbia
University, New York, NY
2 Herbert Irving Comprehensive Cancer Center, Columbia
University, New York, NY
3 Fred Hutchinson Cancer Research Center, Seattle, WA
4 Vagelos College of Physicians and Surgeons, Columbia
University, New York, NY
5 Irving Institute for Clinical and Translational
Research, Columbia University, New York, NY
6 Department of Pathology and Cell Biology, Columbia
University, New York, NY
7 Department of Neurology, Columbia University, New
York, NY